Trial intelligence / Profile preview

Oral Liposomal Iron vs IV Iron Sucrose in Non-Dialysis CKD

NCT06556134Phase 4Completed

Sponsor
Centre Hospitalier Universitaire Hassan II
Start
Jul 2021
Primary completion
Jul 2023
Modality
DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Covalent Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Iron protein succinylate in anemia of chronic kidney disease (CKD-A), sponsored by Centre Hospitalier Universitaire Hassan II. Started Jul 2021; status: completed.

02

Drugs

Iron protein succinylate
03

Conditions

anemia of chronic kidney disease (CKD-A)

Beyond the preview

Go deeper on NCT06556134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06556134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call